// App-Quantinova.ai

AB0775 : HAS RITUXIMAB (RTX) A ROLE IN TREATMENT OF CHRONIC NON-RENAL HENOCH-SCHONLEIN PURPURA (HSP)? 9 YEARS FOLLOW UP OF A PATIENT WITH SEVERE GASTRO-INTESTINAL DISEASE

Researchers

Presenter

  • S. Tosounidou

Principal Investigators

  • M. Sahni

  • D. Carruthers

Medical Centers

  • Sandwell and West Birmingham Hospital NHS Trust, Birmingham, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Allergic purpura

  • Anti-neutrophil cytoplasmic antibody-associated vasculitis

  • Venous thrombosis

Biomarkers

  • Cluster of differentiation 79A

  • Interleukin 1 alpha

Drug/Treatment

  • Methylprednisolone

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Oraprine

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved